Amyris Investors' $13.5M Deal Over Inflated Royalties OK'd
By Gina Kim ( July 25, 2022, 6:26 PM EDT) -- A California federal judge on Friday greenlighted a $13.5 million class action settlement resolving claims from investors who accused chemical products manufacturer Amyris Inc. of overstating its royalty revenues from a company licensed to use its chemical farnesene to make vitamin E-based products, which caused Amyris stock prices to eventually sink. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.